C2N Diagnostics Receives $20M Program-Related Investment from GHR Foundation to Bring Alzheimer's Blood Test to the Clinic – Business Wire
C2N Diagnostics Receives $20M Program-Related Investment from GHR Foundation to Bring Alzheimer’s Blood Test to the Clinic Business Wire
Source: Investment New Feed